Recall Register

Food, drugs, devices › Tosoh Bioscience Inc

Device recall: Tosoh¿Automated Enzyme Immunoassay Analyzer AIA-900, Product Catalog No. 022930. Product Usage: The AIA-900 Automated En

FDA enforcement event 78776 · Class II · initiated 11 Jun 2017 · status Terminated · terminated 31 Dec 2019

DeviceVoluntary: Firm initiated2 product recordsGrove City, OH

Tosoh Bioscience Inc (Grove City, OH) initiated this device recall on 11 Jun 2017; FDA lists 2 product records under event 78776, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 93% of the 1,091 device enforcement events initiated in 2017 carry the same class.

Status: Terminated, terminated 31 Dec 2019. Initiation: voluntary: firm initiated. Tosoh Bioscience Inc has 27 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Tosoh Bioscience Inc, Grove City, OH.

Reason for recall

"This recall has been initiated due to a potential malfunction of the photo interrupter (Pl). The potential malfunction has been attributed to aging and premature deterioration of the Pl collector current."

Distribution

"Worldwide Distribution - U.S. Nationwide - Latin America"

Product records

Recall numberProductQuantityClassStatusReport date
Z-0491-2018Tosoh¿Automated Enzyme Immunoassay Analyzer AIA-900, Product Catalog No. 022930. Product Usage: The AIA-900 Automated Enzyme Immunoassay System is an automated analyzer for in vitro diagnostic use that measures a variety of substances in serum, plasma, and or urine using the AIA-PACK reagent series.565 total devices U.S.Class IITerminated7 Feb 2018
Z-0492-2018Tosoh¿Sorter 9tray, Product Code 022931and Tosoh¿Sorter 19tray, Product Code 022932. Product Usage: The AIA-900 9tray Sorter and AIA-900 19tray Sorter supports the automation of the AIA-900 systems.565 total devices U.S.Class IITerminated7 Feb 2018

Context

93%of 2017 device events are Class II1,091 events that year
2product records in this eventfirm median: 1
27events on this register for the firm

Other enforcement events for Tosoh Bioscience Inc

InitiatedProduct (first record)TypeClassRecords
12 Jun 2026ST AIA-Pack Testosterone, IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of testosterone in human serum oDeviceClass II1
7 Aug 2020Tosoh Bioscience AIA- PACK HCG Calibrator Set-In Vitro Diagnostic for BHCG Part number 020361 The AIA-Pack BHCG CalibratDeviceClass II2
22 May 2020AIA-900 Analyzer, Part no. 022930, UDI 04560189283992DeviceClass II1
10 Jan 2020AIA-360 Automated Immunoassay Analyzer, Product Code 019945DeviceClass II1
30 Nov 2018AIA-PACK B12 (Vitamin B12) is designed for IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of vitamin B12 DeviceClass II6
5 Oct 2018Hemoglobin A1c Control, Part no. 220232 for use as quality control material to monitor the precision of laboratory testiDeviceClass III1
5 Oct 2018AIA-900 Automated Immunoassay Analyzer, product code 022930 /022930R Product Usage: The AIA-900 is capable of performingDeviceClass II1
5 Oct 2018AIA-900 Analyzer, Product code 022930, 022930RDeviceClass II1
28 Sep 2018AIA-2000 Analyzer, Model Nos. AIA-2000LA, AIA-2000ST - Product Usage: The AIA-2000 is capable of performing three methodDeviceClass II1
28 Sep 2018Tosoh AIA-900 immunoassay AnalyzerDeviceClass II1

All 27 events for Tosoh Bioscience Inc

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "This recall has been initiated due to a potential malfunction of the photo interrupter (Pl). The potential malfunction has been attributed to aging and premature deterioration of the Pl collector current."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide Distribution - U.S. Nationwide - Latin America"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 31 Dec 2019. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.